We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
139 hedge funds and large institutions have $299M invested in Esperion Therapeutics in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 25
2% less funds holding
Funds holding: 142 → 139 (-3)
10% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 39
12.7% less ownership
Funds ownership: 100.53% → 87.84% (-13%)
19% less call options, than puts
Call options by funds: $9.22M | Put options by funds: $11.4M
50% less capital invested
Capital invested by funds: $598M → $299M (-$299M)
Holders
139
Holders Change
-3
Holders Change %
-2.11%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
35
Reduced
39
Closed
25
Calls
$9.22M
Puts
$11.4M
Net Calls
-$2.14M
Net Calls Change
+$4.23M
Top Buyers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$3.69M |
| 2 |
Voloridge Investment Management
Jupiter,
Florida
|
+$2.79M |
| 3 |
HF
HRT Financial
New York
|
+$2.69M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.32M |
| 5 |
Millennium Management
New York
|
+$2.19M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$24.4M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$10.6M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$9.49M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$8.46M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$7.17M |
